Regeneron (REGN) Announces Dupixent is Now Approved in European Union for Severe Chronic Rhinosinusitis with Nasal Polyposis

Go back to Regeneron (REGN) Announces Dupixent is Now Approved in European Union for Severe Chronic Rhinosinusitis with Nasal Polyposis
Regeneron (NASDAQ: REGN) Delayed: 618.03 +5.53 (0.90%)
Previous Close $612.50    52 Week High $592.36 
Open $607.92    52 Week Low $325.35 
Day High $621.79    P/E 162.21 
Day Low $607.92    EPS $3.81 
Volume 1,279,853       

SANOFI (NASDAQ: SNY) Delayed: 41.60 -0.18 (0.43%)
Previous Close $41.78    52 Week High $44.76 
Open $42.27    52 Week Low $36.81 
Day High $42.47    P/E N/A 
Day Low $41.47    EPS $0.00 
Volume 10,855,605